TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
SAN FRANCISCO, March 31, 2026 BUSINESS WIRE )--TippingPoint Biosciences today announced the closing of an oversubscribed $4.5 million seed financing to advance a breakthrough drug discovery platform that targets epigenetic protein interfaces long considered "undruggable," opening a new frontier in precision medicine. The financing was led by SOSV and LKS Fund, with participation from a syndicate of leading investors including Sazze Partners, Freeflow Ventures, StoryHouse Ventures, Sontag Innovation Fund, American Cancer Society BrightEdge, XEIA and WeCAN. The company was co-founded by Laura Hsieh, PhD, and renowned chromatin biologist Geeta Narlikar, PhD, of the University of California, San Francisco (UCSF). Hsieh developed the underlying technology during her postdoctoral research in Narlikar's laboratory, which is widely recognized for tackling some of the most challenging mechanistic problems in chromatin biology and genome regulation. Despite billions of dollars invested ove
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® [Yahoo! Finance]Yahoo! Finance
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®PR Newswire
- AbbVie to Host First-Quarter 2026 Earnings Conference CallPR Newswire
- 3 Asian Growth Companies With High Insider Ownership Growing Revenues Up To 24% [Yahoo! Finance]Yahoo! Finance
- Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)PR Newswire
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/23/26 - Form ARS
- 3/23/26 - Form DEFA14A
- ABBV's page on the SEC website